Testing capitalisation of an internally generated intangible asset means first testing whether the spend under review is research or development as Ind AS 38 defines those terms, because research expenditure is always expensed with no exception, and then, only for development expenditure, testing each of the six specific criteria the standard requires to be met before any cost can be recognised as an asset: technical feasibility, intention to complete, ability to use or sell it, how it will generate probable future economic benefit, availability of adequate resources to complete it, and the ability to measure the expenditure attributable to it reliably.
Why the research-versus-development split comes first
Entities capitalising software or product development costs sometimes jump straight to the six criteria and apply them to the whole project. That skips the gating question: expenditure incurred while the entity is still investigating options, evaluating alternatives, or conducting feasibility studies before a specific product or process has been identified is research, by definition, and no amount of evidence against the six criteria can capitalise it.
The testing sequence
- 01Obtain the project plan and the cost ledger for the development activityIncluding the stage gates the entity itself uses to track the project, which are often the clearest internal evidence of when research activity ended and development activity began.
- 02Identify the point at which the project moved from research to developmentLook for the moment a specific product, process or software module was identified and a decision was made to proceed with it, as distinct from an earlier period spent evaluating whether to proceed at all. Costs before that point are expensed regardless of how the six criteria would otherwise be assessed.
- 03Test technical feasibility as at the capitalisation start date, not with hindsightThe evidence should exist as at the date capitalisation began — a technical design document, a working prototype, or a feasibility study — not be reconstructed later from the fact that the project ultimately succeeded.
- 04Test the entity's intention and ability to complete the asset and use or sell itBoard or management approval of the project, budget allocation for completion, and, for an asset to be sold, evidence of a market or specific customer demand.
- 05Test how the asset will generate probable future economic benefitFor an internal-use asset, evidence of the efficiency or cost saving it is expected to deliver; for an asset to be sold, a business case or market assessment. A generic statement that the project 'is expected to be useful' is not sufficient evidence.
- 06Test the availability of adequate technical, financial and other resources to complete the projectStaffing plans, budget approval covering the remaining cost to completion, and, where external financing is needed to complete the project, evidence that financing is actually available.
- 07Recompute the directly attributable costs capitalisedEmployee costs for time actually spent on the development activity, materials and services consumed, and a reasonable allocation of overheads directly attributable to generating the asset — general administrative overhead, selling costs, and identified inefficiencies or losses during development are excluded.
- 08Test for costs that should have stopped being capitalisedCapitalisation stops once the asset is capable of operating as intended by management; costs incurred after that point, including costs associated with maintaining or running the asset, should be expensed, not folded into the carrying amount.
| Criterion | Evidence |
|---|---|
| Technical feasibility | Design document, working prototype, feasibility study dated before or at capitalisation start |
| Intention to complete | Project approval, allocated budget for completion |
| Ability to use or sell | Internal usage plan, or market or customer evidence for an asset to be sold |
| Probable future economic benefit | Business case, expected cost saving or revenue, tested for reasonableness |
| Availability of resources | Staffing and funding plan covering the remaining cost to completion |
| Reliable measurement of cost | Timesheets or allocation basis for employee cost, materials and directly attributable overhead |
A project capitalised from its earliest stage, with no identifiable point where research activity ended, is a common finding where capitalisation has simply tracked the whole project budget rather than the specific expenditure that met all six criteria from a specific date.
How we think about this
Recomputing the directly attributable cost from timesheets and invoices is arithmetic. Deciding where research ends and development begins, and whether the evidence for each of the six criteria existed at the time rather than being assembled afterwards because the project succeeded, is the judgement this working paper actually tests.
This is practical guidance written for audit teams, not an authoritative statement of any standard or statute. Standards, forms and timelines change. Check the current text issued by the ICAI and the relevant authority before relying on anything here in an audit file.
Related resources
- Fixed assets & capexInd AS 38: intangible assets, and why most internally generated ones never make the balance sheetResearch is always expensed. Development can be capitalised, but only once six specific conditions are all met — a much stricter bar than it sounds.
- Fixed assets & capexPharmaceutical company audit: R&D capitalization and regulatory write-offsMost pharma R&D spend should be expensed, not capitalised, because the Ind AS 38 recognition criteria aren't met until regulatory approval is near-certain. Testing that project by project is the audit.
- Fixed assets & capexCapex vs revenue expenditure: the audit testThe capitalisation criteria, the repairs-versus-improvement judgement calls that actually come up, and how to sample repairs and maintenance for misclassified capex.
- Fixed assets & capexHow to test intangible asset impairment indicatorsCheck the internal and external indicators first, then decide whether a full recoverable-amount test is unavoidable — and document the conclusion either way.
Free tools, no signup
Each one reads a file entirely in your browser — or, for two of them, just answers a few questions — and nothing is ever uploaded.
- Purchase register checkDuplicate payments, round-sum amounts, weekend-dated invoices, incomplete records.
- GSTR-2B reconcilerMatches your purchase register against GSTR-2B — missing invoices either side, amount mismatches.
- Bank reconciliation checkerMatches your cash book against a bank statement — what's outstanding on each side.
- Fixed asset register checkDuplicate asset codes, missing location or useful life, negative net book value.
- Payroll red-flag scannerBank accounts shared across employees, and records missing an ID, PAN or salary.
- CARO applicability checkerAnswer a few questions about the company and see which CARO 2020 clauses likely apply.
- MSME payment delay checkerMSME-flagged invoices paid — or still unpaid — beyond the 45-day Section 22 limit.
- Related-party transaction screenerTransactions above a threshold you set with no approval reference, grouped by counterparty.
- Depreciation useful life checkerCompares a useful life in use against the Schedule II, Part C indicative figure.
- Materiality calculatorOverall and performance materiality against PBT, revenue, assets or equity, with reasoning shown.
- Sample size calculatorStatistical sample size for a test of controls or a substantive test of detail.